New study aims to untangle two similar brain diseases
NCT ID NCT07304960
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will compare 100 people with either multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) to find better ways to tell them apart. Researchers will measure specific proteins in the blood and look at MRI scans. The goal is to improve diagnosis and management for these often-confused conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better distinguish between MS and NMOSD, leading to more accurate diagnoses and tailored treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may not change current practice immediately.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MS (MULTIPLE SCLEROSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Magic mushroom therapy tested for depression in chronic illness patients
- New study observes patients getting nasal stem cell therapy for brain conditions
- Weighted vest rehab shows promise for MS walking problems
- MS patients switch meds: will a cheaper option work just as well?
- Could an electric suit ease MS stiffness and clumsiness?
- Your Phone's selfie camera could be the new MS monitor